Form 4 Filing for Editas Medicine, Inc.

This Form 4 filing reports a transaction by Amy Parison, the SVP, Chief Financial Officer of Editas Medicine, Inc. On September 3, 2026, Ms. Parison disposed of 453 shares of Common Stock at a price of $3.0372 per share. This sale was executed under a pre-existing automatic sales instruction plan to cover tax withholding obligations arising from the vesting of restricted stock units on September 2, 2026. The sale is not considered a discretionary trade. Following the transaction, Ms. Parison holds 13,839 shares of Common Stock. The filing was signed by Amy Parison on September 4, 2026.